rs4987856

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

lymphocyte count

Allele T
OR 0.02
p 1.0e-14
N 394,642
Large GWAS
European

apoptosis regulator BCL-2 measurement

Allele T
OR 0.07
p 2.0e-13
N 47,745
Large GWAS
European

chronic lymphocytic leukemia

Allele C
OR 1.45
p 4.0e-11
N 10,767
Meta-analysisLarge GWAS
multi-ancestry

Thyroid stimulating hormone level

Allele T
OR 0.02
p 3.0e-10
N 482,873
Large GWAS
European

Research that mentions this SNP (1)

Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder
AssociationN=179Jochen Hess et al.(2017)· Journal of Cancer Research and Clinical Oncology

This study examined three BCL2 single-nucleotide polymorphisms (c.-938C>A rs2279115, c.21G>A rs1801018, and c.*2203A>G rs4987853) in 179 bladder cancer patients and found significant associations with survival outcomes. The c.-938C>A polymorphism was associated with relapse-free survival (p=0.024), while c.21G>A showed stronger associations with both relapse-free survival (p=0.009) and progression-free survival (p=0.012), demonstrating pronounced allele dose effects in both cases. The c.*2203A>G polymorphism showed no significant survival associations.

Traits studied:Bladder cancerOverall survivalProgression-free survivalRelapse-free survivalTransitional cell carcinoma of the bladder

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…